Gotham Asset Management LLC boosted its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 388.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 198,050 shares of the company's stock after purchasing an additional 157,483 shares during the period. Gotham Asset Management LLC owned approximately 0.43% of Azenta worth $9,902,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Focus Partners Wealth raised its stake in Azenta by 7.2% in the 4th quarter. Focus Partners Wealth now owns 13,738 shares of the company's stock worth $690,000 after acquiring an additional 921 shares during the last quarter. Deutsche Bank AG raised its stake in shares of Azenta by 28.5% in the fourth quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after purchasing an additional 931 shares during the last quarter. Corton Capital Inc. purchased a new position in shares of Azenta in the fourth quarter worth about $295,000. Captrust Financial Advisors lifted its holdings in shares of Azenta by 22.1% during the fourth quarter. Captrust Financial Advisors now owns 11,179 shares of the company's stock worth $559,000 after purchasing an additional 2,026 shares during the period. Finally, Caxton Associates LP purchased a new stake in Azenta in the fourth quarter valued at approximately $1,598,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.
Azenta Stock Down 0.9%
Shares of AZTA stock traded down $0.23 during trading hours on Thursday, hitting $26.71. 976,302 shares of the company's stock were exchanged, compared to its average volume of 674,129. Azenta, Inc. has a fifty-two week low of $23.91 and a fifty-two week high of $63.58. The firm has a market cap of $1.22 billion, a P/E ratio of -8.96 and a beta of 1.64. The firm has a 50 day moving average of $30.60 and a two-hundred day moving average of $41.75.
Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. During the same quarter in the previous year, the firm posted $0.06 EPS. Azenta's revenue was up 5.1% compared to the same quarter last year. On average, equities analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th. Needham & Company LLC decreased their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Finally, Evercore ISI raised their target price on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a report on Thursday, February 6th.
Get Our Latest Analysis on AZTA
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.